Cargando…

Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis

Metabolic syndrome (MetS) is a predictor of several diseases such as cardiovascular diseases, diabetes, dyslipidemia, stroke, osteoarthritis, certain cancers, and death leading to public health concern in most societies. We aimed to estimate the pooled prevalence and incidence of MetS in Iranian pop...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatahi, Azad, Doosti-Irani, Amin, Cheraghi, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297433/
https://www.ncbi.nlm.nih.gov/pubmed/32577194
http://dx.doi.org/10.4103/ijpvm.IJPVM_489_18
_version_ 1783547004984492032
author Fatahi, Azad
Doosti-Irani, Amin
Cheraghi, Zahra
author_facet Fatahi, Azad
Doosti-Irani, Amin
Cheraghi, Zahra
author_sort Fatahi, Azad
collection PubMed
description Metabolic syndrome (MetS) is a predictor of several diseases such as cardiovascular diseases, diabetes, dyslipidemia, stroke, osteoarthritis, certain cancers, and death leading to public health concern in most societies. We aimed to estimate the pooled prevalence and incidence of MetS in Iranian population through a meta-analysis study. We included cross-sectional and cohort studies to estimate the overall prevalence and incidence rates of MetS in Iran National databases including MagIran, Science Information Database, IranMedex, and international databases including Medline, Web of Sciences, and Scopus were searched up to October 2017. Finally, 125 studies were included. The total sample size was 472,401 with a mean age of 38 ± 7.8 years. The overall pooled prevalence and incidence rate among the general population of Iran was 0.26 (95% CI: 0.26, 0.29) and 97.96 (95% CI: 75.98, 131.48), respectively. The pooled prevalence of MetS was higher in females and in urban areas. The highest and lowest prevalence of MetS was obtained by the Iranian definition criteria (0.43) and the NHANES III (0.12). The highest and lowest incidence rates of MetS were obtained by IDF (144.07 per 1000) and the JIS (89.73 per 1000). The prevalence of MetS was higher in women and those living in urban areas. Furthermore, the prevalence of MetS increased with increasing age in both genders.
format Online
Article
Text
id pubmed-7297433
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-72974332020-06-22 Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis Fatahi, Azad Doosti-Irani, Amin Cheraghi, Zahra Int J Prev Med Review Article Metabolic syndrome (MetS) is a predictor of several diseases such as cardiovascular diseases, diabetes, dyslipidemia, stroke, osteoarthritis, certain cancers, and death leading to public health concern in most societies. We aimed to estimate the pooled prevalence and incidence of MetS in Iranian population through a meta-analysis study. We included cross-sectional and cohort studies to estimate the overall prevalence and incidence rates of MetS in Iran National databases including MagIran, Science Information Database, IranMedex, and international databases including Medline, Web of Sciences, and Scopus were searched up to October 2017. Finally, 125 studies were included. The total sample size was 472,401 with a mean age of 38 ± 7.8 years. The overall pooled prevalence and incidence rate among the general population of Iran was 0.26 (95% CI: 0.26, 0.29) and 97.96 (95% CI: 75.98, 131.48), respectively. The pooled prevalence of MetS was higher in females and in urban areas. The highest and lowest prevalence of MetS was obtained by the Iranian definition criteria (0.43) and the NHANES III (0.12). The highest and lowest incidence rates of MetS were obtained by IDF (144.07 per 1000) and the JIS (89.73 per 1000). The prevalence of MetS was higher in women and those living in urban areas. Furthermore, the prevalence of MetS increased with increasing age in both genders. Wolters Kluwer - Medknow 2020-06-03 /pmc/articles/PMC7297433/ /pubmed/32577194 http://dx.doi.org/10.4103/ijpvm.IJPVM_489_18 Text en Copyright: © 2020 International Journal of Preventive Medicine http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Fatahi, Azad
Doosti-Irani, Amin
Cheraghi, Zahra
Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis
title Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis
title_full Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis
title_fullStr Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis
title_full_unstemmed Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis
title_short Prevalence and Incidence of Metabolic Syndrome in Iran: A Systematic Review and Meta-Analysis
title_sort prevalence and incidence of metabolic syndrome in iran: a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297433/
https://www.ncbi.nlm.nih.gov/pubmed/32577194
http://dx.doi.org/10.4103/ijpvm.IJPVM_489_18
work_keys_str_mv AT fatahiazad prevalenceandincidenceofmetabolicsyndromeiniranasystematicreviewandmetaanalysis
AT doostiiraniamin prevalenceandincidenceofmetabolicsyndromeiniranasystematicreviewandmetaanalysis
AT cheraghizahra prevalenceandincidenceofmetabolicsyndromeiniranasystematicreviewandmetaanalysis